Paris, France

Giovanna Barba-Spaeth

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Giovanna Barba-Spaeth: Innovator in Anti-Dengue Vaccines

Introduction

Giovanna Barba-Spaeth is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the development of anti-dengue vaccines. With a total of 2 patents, her work is paving the way for advancements in dengue virus treatment and prevention.

Latest Patents

Her latest patents focus on the creation of a Dengue virus Envelope Dimer Epitope (EDE). This innovative approach involves a dimer of Envelope proteins that can span the polypeptides of a Dengue virus Envelope polypeptide dimer. The EDE is designed to be a stabilized recombinant dengue virus envelope glycoprotein E ectodomain (sE) dimer. This dimer can be covalently stabilized through various methods, including disulphide inter-chain bonds and sulfhydryl-reactive crosslinkers. Additionally, the EDE can neutralize multiple Dengue virus serotypes, showcasing its potential as a versatile therapeutic option.

Career Highlights

Giovanna has worked with esteemed institutions such as Université Paris-Saclay and Imperial College Innovations Limited. Her research has been instrumental in advancing the understanding of dengue virus and developing effective vaccines.

Collaborations

Some of her notable coworkers include Juthathip Mongkolsapaya and Alexander Rouvinski. Their collaborative efforts have contributed to the success of her research initiatives.

Conclusion

Giovanna Barba-Spaeth is a trailblazer in the field of vaccine development, particularly for dengue virus. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…